Silexion Therapeutics Corp (SLXNW) Net income 2023–2025
Silexion Therapeutics Corp (SLXNW) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$11.9MFY2025 · since FY2023: -$5.1M → -$11.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$11.9M | +27.9% |
| FY2024 | -$16.5M | -223.4% |
| FY2023 | -$5.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SLXNW financial trends
SLXNW RevenueSLXNW Net marginSLXNW Gross profitSLXNW Gross marginSLXNW Operating incomeSLXNW Operating marginSLXNW Operating cash flowSLXNW Free cash flowSLXNW Capital expendituresSLXNW Return on equitySLXNW Stock buybacksSLXNW Dividends paidSLXNW Total assetsSLXNW Total liabilitiesSLXNW Shareholders’ equitySLXNW overview →